2023-2024 Regular Session • Delaware Legislature
HB364: An Act To Amend Title 18 Of The Delaware Code Relating To Cancer Coverage.
Legislative Summary
This Act requires that individual, blanket, and group health insurance carriers cover drug treatment for the associated conditions of metastatic cancer in the same way treatment for metastatic cancer is covered. Specifically, it requires insurance companies to cover any FDA approved drug prescribed to treat the side effects of metastatic cancer treatment and prohibits insurance companies from mandating that patients first fail to respond to a different drug or prove a history of failure of such drug. Technical changes are also made to comply with the Delaware Legislative Drafting Manual.
Bill History
4/11/2024
Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
4/16/2024
Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 5 Favorable, 4 On Its Merits
6/11/2024
Passed By House. Votes: 39 YES 2 ABSENT
6/11/2024
Assigned to Banking, Business, Insurance & Technology Committee in Senate
6/18/2024
Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 1 Favorable, 5 On Its Merits
6/25/2024
Passed By Senate. Votes: 21 YES
8/2/2024
Signed by Governor
Roll Call Votes
Senate Third Reading
6/25/2024
21
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
House Third Reading
6/11/2024
39
Yea
0
Nay
0
Not Voting
2
Absent
Result: PASSED
Status Information
Current Status
Passed(8/2/2024)
Chamber
House of Representatives
Sine DiePrior Session
Sponsors
Democrat: 12
Republican: 1
Primary Sponsor
Cyndie Romer
Democrat